Literature DB >> 24777110

Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer.

William F Anderson1, Philip S Rosenberg1, Hormuzd A Katki2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24777110      PMCID： PMC4677264          DOI： 10.1093/jnci/dju093

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  29 in total

1.  Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.

Authors:  Christina A Clarke; Theresa H M Keegan; Juan Yang; David J Press; Allison W Kurian; Anish H Patel; James V Lacey
Journal:  J Natl Cancer Inst       Date:  2012-07-05       Impact factor: 13.506

2.  Carcinoma of the breast; results from statistical research.

Authors:  J CLEMMESEN
Journal:  Br J Radiol       Date:  1948-12       Impact factor: 3.039

3.  Possible relationship between menopause and age at onset of breast cancer.

Authors:  E ANDERSON; S C REED; R A HUSEBY; C P OLIVER
Journal:  Cancer       Date:  1950-05       Impact factor: 6.860

4.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

5.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

6.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

7.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors:  Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

8.  Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

Authors:  Edward H Romond; Edith A Perez; John Bryant; Vera J Suman; Charles E Geyer; Nancy E Davidson; Elizabeth Tan-Chiu; Silvana Martino; Soonmyung Paik; Peter A Kaufman; Sandra M Swain; Thomas M Pisansky; Louis Fehrenbacher; Leila A Kutteh; Victor G Vogel; Daniel W Visscher; Greg Yothers; Robert B Jenkins; Ann M Brown; Shaker R Dakhil; Eleftherios P Mamounas; Wilma L Lingle; Pamela M Klein; James N Ingle; Norman Wolmark
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

9.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

10.  Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer.

Authors:  Nadia Howlader; Anne-Michelle Noone; Mandi Yu; Kathleen A Cronin
Journal:  Am J Epidemiol       Date:  2012-07-25       Impact factor: 4.897
View more
  17 in total

Review 1.  AMP-activated protein kinase and energy balance in breast cancer.

Authors:  Hong Zhao; Yelda C Orhan; Xiaoming Zha; Ecem Esencan; Robert T Chatterton; Serdar E Bulun
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

Review 2.  Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches.

Authors:  Muhammad Tufail; Jia Cui; Changxin Wu
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

Review 3.  Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer.

Authors:  Song Xia; Qiong Lin
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 4.  Aromatase expression and regulation in breast and endometrial cancer.

Authors:  Hong Zhao; Ling Zhou; Anna Junjie Shangguan; Serdar E Bulun
Journal:  J Mol Endocrinol       Date:  2016-04-11       Impact factor: 5.098

5.  Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004-2013): Amassing data from independent Western populations provide etiologic clues.

Authors:  Maeve Mullooly; Jeanne Murphy; Gretchen L Gierach; Paul M Walsh; Sandra Deady; Thomas I Barron; Mark E Sherman; Philip S Rosenberg; William F Anderson
Journal:  Eur J Cancer       Date:  2017-10-23       Impact factor: 9.162

6.  Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library.

Authors:  Huijuan Jin; Xiaojie Gao; Li Xiao; Huimin He; Sinan Cheng; Caixia Zhang; Yifan Hou; Fengying Song; Xiaorong Su; Qian Gao; Zheng Lu; Ruina Yang; Xigui Song; Jin Yang; Wei Duan; Yingchun Hou
Journal:  Biotechnol Lett       Date:  2020-11-03       Impact factor: 2.461

Review 7.  Luminal A Breast Cancer and Molecular Assays: A Review.

Authors:  Jennifer J Gao; Sandra M Swain
Journal:  Oncologist       Date:  2018-02-22

8.  Revisiting social MPE: an integration of molecular pathological epidemiology and social science in the new era of precision medicine.

Authors:  Jin Dai; Akihiro Nishi; Nathan Tran; Yasumasa Yamamoto; George Dewey; Tomotaka Ugai; Shuji Ogino
Journal:  Expert Rev Mol Diagn       Date:  2021-07-26       Impact factor: 5.670

9.  Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.

Authors:  Betsy A Kohler; Recinda L Sherman; Nadia Howlader; Ahmedin Jemal; A Blythe Ryerson; Kevin A Henry; Francis P Boscoe; Kathleen A Cronin; Andrew Lake; Anne-Michelle Noone; S Jane Henley; Christie R Eheman; Robert N Anderson; Lynne Penberthy
Journal:  J Natl Cancer Inst       Date:  2015-03-30       Impact factor: 13.506

10.  The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes.

Authors:  Carol A Parise; Vincent Caggiano
Journal:  J Cancer Epidemiol       Date:  2015-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.